The dose-dependent effect of acute ozone exposure on lung function and the efficacy of a Boysenberry apple powder blend (BerriQi®) in reducing throat irritation and symptom recovery time in healthy adults

• Exposure to 0.2 ppm ozone for 2 h caused significant FVC and FEV1 reductions. • BerriQi significantly reduced ozone-induced throat irritation compared to placebo. • BerriQi expedited the resolution of ozone-induced respiratory irritation symptoms. • Preliminary findings show BerriQi's potential for protecting respiratory health. Urbanization and industrialization have impacted air quality and health, with ozone exposure linked to reduced lung function and increased respiratory issues. This study characterised the dose-dependent effect of acute, controlled ambient ozone exposure in an environmental chamber on lung function, then investigated the effect of BerriQi® Boysenberry and apple powder (BerriQi) ozone-induced respiratory irritation symptoms. In an incremental dose study, healthy adults were exposed to 0.1, 0.2 or 0.3 ppm ozone for 2 h. Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) were measured at designated timepoints up to 48 h after ozone exposure. This was followed by a randomised, double-blind, placebo-controlled crossover trial, with healthy adults (n = 20) who consumed either BerriQi or a placebo daily for 5 days before being exposed to 0.2 ppm ozone for 2 h. Respiratory irritation symptoms, including throat irritation (TI), soreness of cough (SOC), shortness of breath (SOB), and pain on deep inspiration (PODI), were assessed at designated timepoints up to 48 h after ozone exposure. Our results showed that 0.2 ppm ozone was the maximum tolerated dose that elicited a temporal decline in lung function in healthy participants and that BerriQi supplementation significantly reduced TI (p = 0.04), and may expedite the resolution of SOC, SOB and PODI after acute ozone exposure. These findings suggest that BerriQi may alleviate the severity and duration of ozone-induced respiratory irritation and highlights the potential of BerriQi as a dietary intervention for mitigating the respiratory effects of air pollution.

Authors

Institutions

Publication Details

Journal
Hygiene and Environmental Health Advances
Published
2025-06-08
DOI
https://doi.org/10.1016/j.heha.2025.100132
Citations
1
Primary Topic
Air Quality and Health Impacts
Type
article
Field-Weighted Citation Impact
1.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The dose-dependent effect of acute ozone exposure on lung function and the efficacy of a Boysenberry apple powder blend (BerriQi®) in reducing throat irritation and symptom recovery time in healthy adults

Dominic Lomiwes, Gregory M. Sawyer, Alexander P. Kanon, Nayer Ngametua et al.
1 citations
Hygiene and Environmental Health Advances
Air Quality and Health Impacts
1.20
article

The dose-dependent effect of acute ozone exposure on lung function and the efficacy of a Boysenberry apple powder blend (BerriQi®) in reducing throat irritation and symptom recovery time in healthy adults

Dominic Lomiwes, Gregory M. Sawyer, Alexander P. Kanon, Nayer Ngametua, Odette M. Shaw, Matthew J. Barnes, Grayson Nicholls, Gowthami Vangala
article en
1 citations

Abstract

• Exposure to 0.2 ppm ozone for 2 h caused significant FVC and FEV1 reductions. • BerriQi significantly reduced ozone-induced throat irritation compared to placebo. • BerriQi expedited the resolution of ozone-induced respiratory irritation symptoms. • Preliminary findings show BerriQi's potential for protecting respiratory health. Urbanization and industrialization have impacted air quality and health, with ozone exposure linked to reduced lung function and increased respiratory issues. This study characterised the dose-dependent effect of acute, controlled ambient ozone exposure in an environmental chamber on lung function, then investigated the effect of BerriQi® Boysenberry and apple powder (BerriQi) ozone-induced respiratory irritation symptoms. In an incremental dose study, healthy adults were exposed to 0.1, 0.2 or 0.3 ppm ozone for 2 h. Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) were measured at designated timepoints up to 48 h after ozone exposure. This was followed by a randomised, double-blind, placebo-controlled crossover trial, with healthy adults (n = 20) who consumed either BerriQi or a placebo daily for 5 days before being exposed to 0.2 ppm ozone for 2 h. Respiratory irritation symptoms, including throat irritation (TI), soreness of cough (SOC), shortness of breath (SOB), and pain on deep inspiration (PODI), were assessed at designated timepoints up to 48 h after ozone exposure. Our results showed that 0.2 ppm ozone was the maximum tolerated dose that elicited a temporal decline in lung function in healthy participants and that BerriQi supplementation significantly reduced TI (p = 0.04), and may expedite the resolution of SOC, SOB and PODI after acute ozone exposure. These findings suggest that BerriQi may alleviate the severity and duration of ozone-induced respiratory irritation and highlights the potential of BerriQi as a dietary intervention for mitigating the respiratory effects of air pollution.

Hygiene and Environmental Health AdvancesVol. 15
Plant & Food Research (NZ), Massey University (NZ)
Zero hunger
Openalex Percentile: Top 22%
Air Quality and Health Impacts
1.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.